Financial Results for the First Quarter of Fiscal Year Ending March 31, 2020 (FY2019)

from the beginning

Financial Results for the First Quarter of Fiscal Year Ending March 31, 2020 (FY2019)

• Profit Above the Guidance with Double Digit Growth

• Adjusted Operating Profit Variance Analysis

• Revenue by Region

• Revenue by Business Segment

• Cardiac and Vascular : Double Digit Growth in Revenue and Profit

• General Hospital : A Start Largely in Line with the Guidance

• Blood Management : Revenue Slightly Behind the Plan,Profit as Planned

• Major Topics in FY19 Q1

• New Products Pipeline in FY19

• Enhances Coronary Interventional Product Portfolio

Reference

• FY19 Q1 Revenue and Growth by Region

• Operating Expenses

• Quarterly Results

• Adjusted Operating Profit : Adjustments

• CAPEX and R&D Expenses

• Cash Flows

• Foreign Exchange Sensitivity

• The Status of Convertible Bonds

• IR Contact